These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7770018)

  • 21. [The new effective anticestodian agent fluxane].
    Trusov SN; Mikhaĭlitsyn FS; Sevbo DP; Arkhipov IA; Koveshnikova EI
    Med Parazitol (Mosk); 2006; (2):22-4. PubMed ID: 16813243
    [No Abstract]   [Full Text] [Related]  

  • 22. [The search for new antiparasitic agents. 7. A study of the relationship between the structure and the anthelmintic activity of new halogen-containing benzamides].
    Mikhaĭlitsyn FS; Lebedeva MN; Baiandina DG; Dzhabarova VI; Lychko ND; Kozyreva NP; Bolotina LA; Naĭdenova AS
    Med Parazitol (Mosk); 1991; (5):53-5. PubMed ID: 1758367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Synthesis and study of the acute toxicity and antiparasitic activity on 6-nitro (amino)-4-dialkylaminoalkylaminoquinolines].
    Bolotina LA; Bekhli AF; Lebedeva MN; Maksakovskaia EV; Naĭdenova AS
    Med Parazitol (Mosk); 1981; 50(2):51-4. PubMed ID: 7015098
    [No Abstract]   [Full Text] [Related]  

  • 24. [The compound MCT-21 and its antihymenolepidose activity].
    Mikhaĭlitsyn FS; Gitsu GA; Sevbo DP; Trusov SN; Bolotina LA
    Med Parazitol (Mosk); 2010; (4):54-5. PubMed ID: 21400712
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antihelmintic activity of polymorphic modifications of phenasal].
    Bekhli AF; Kosheleva LI; Krotov AI; Naĭdenova AS; Gladkikh VF
    Med Parazitol (Mosk); 1976; 45(2):228. PubMed ID: 1024144
    [No Abstract]   [Full Text] [Related]  

  • 26. Imidazo[4,5-f]quinolines. 2. A series of 9-(substituted amino)imidazo[4,5-f]quinolines as antitapeworm agents.
    Spencer CF; Synder HR; Burch HA; Hatton CJ
    J Med Chem; 1977 Jun; 20(6):829-33. PubMed ID: 874958
    [No Abstract]   [Full Text] [Related]  

  • 27. [The preparation and anticestodal activity of the compounds MCT-09 and MCT-11].
    Mikhaĭlitsyn FS; Gitsu GA; Sevbo DP; Trusov SN; Lebedeva MN; Frolova AA; Samochatova EI
    Med Parazitol (Mosk); 2013; (1):41-2. PubMed ID: 23805490
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative evaluation of the antihymenolepic activity of compounds of a series of salicylanilides (benzamides)].
    Gitsu GA; Malakhova AIu; Mikhaĭlitsyn FS; Sevbo DP; Trusov SN; Safarova AIa
    Med Parazitol (Mosk); 2014; (1):44-5. PubMed ID: 24738229
    [No Abstract]   [Full Text] [Related]  

  • 29. [The anticestodal activity of preparations made from the breadfruit].
    Rasfon K
    Med Parazitol (Mosk); 1991; (5):49-52. PubMed ID: 1758366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of mode of infection on the development and chemotherapeutic response of Hymenolepis nana in rats.
    Gupta S; Katiyar JC; Sen AB
    J Helminthol; 1981 Jun; 55(2):101-7. PubMed ID: 7196424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The new agent IMP-1524: design, acute toxicity, and antihymenolepidous activity].
    Mikhaĭlitsyn FS; Lebedeva MN; Gitsu GA; Baiandina DG; Astaf'ev BA; Lychko ND; Uvarova NA; Naĭdenova AS
    Med Parazitol (Mosk); 2005; (2):38-9. PubMed ID: 15984619
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticestode quinolinehydrazones.
    Pellerano C; Savini L; Berkoff CE; Thomas J; Actor P
    Farmaco Sci; 1975 Dec; 30(12):965-73. PubMed ID: 1204834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The technology for manufacturing antiparasitic preparations. 7. Preparation G-1460 and its use for the treatment of monieziasis and intestinal nematodiases].
    Petrov IuF; Mikhaĭlitsyn FS; Bol'shakova AIu; Uvarova NA; Lebedeva MN; Lychko ND
    Med Parazitol (Mosk); 1996; (4):40-2. PubMed ID: 9026673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of various benzimidazole derivatives on susceptibility of albino mice to hymenolepiasis].
    Krotov AI; Baiandina DG; Naĭdenova AS
    Med Parazitol (Mosk); 1977; 46(2):186-7. PubMed ID: 927345
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of hymenolepiasis with 5- and 7-day courses of divided doses of dichlosal and trichlosal].
    Grinenko NV; Arutiunian GK; Kupaev AA; Bereslavich TN
    Med Parazitol (Mosk); 1976; 45(1):101-3. PubMed ID: 1264021
    [No Abstract]   [Full Text] [Related]  

  • 36. Anticestode activity of 3,5-dibromo-2'-chlorosalicylanilide-4'-isothiocyanate--a preliminary report.
    Gupta S; Katiyar JC; Sen AB; Dubey SK; Singh H; Sharma S; Iyer RN
    J Helminthol; 1980 Dec; 54(4):271-3. PubMed ID: 7229321
    [No Abstract]   [Full Text] [Related]  

  • 37. [The anthelminthic alinat and its antihymenolepic activity].
    Mikhaĭlitsyn FS; Gitsu GA; Malakhova AIu; Safarova AIa; Trusov SN; Sevbo DP; Lebedeva MN; Frolova AA; Samochatova EI
    Med Parazitol (Mosk); 2014; (1):43. PubMed ID: 24738228
    [No Abstract]   [Full Text] [Related]  

  • 38. [Regeneration of Hymenolepis nana destroyed by phenasal].
    Isaeva KhB; Arakcheeva SG
    Med Parazitol (Mosk); 1975; 44(6):662-6. PubMed ID: 1214737
    [No Abstract]   [Full Text] [Related]  

  • 39. Design, synthesis, and evaluation of hexahydrobenz[f]isoquinolines as a novel class of dopamine 3 receptor ligands.
    Wu X; Chen J; Ji M; Varady J; Levant B; Wang S
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5813-6. PubMed ID: 15501046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness and tolerable fractional doses of fenesal, dichlosal, and trichlosal in the treatment of patients with hymenolepiasis].
    Grinenko NV; Bereslavich TN; Vishnivetskaia MB; Zhelezova NI; Al'van
    Med Parazitol (Mosk); 1973; 42(2):163-7. PubMed ID: 4805411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.